Chimeric antigen receptors (CARs) from bench-to-bedside.
about
Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesClosely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.Advances in chimeric antigen receptor immunotherapy for neuroblastoma.New immunotherapeutic strategies for the treatment of neuroblastoma.Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.
P2860
Chimeric antigen receptors (CARs) from bench-to-bedside.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chimeric antigen receptors (CARs) from bench-to-bedside.
@en
Chimeric antigen receptors
@nl
type
label
Chimeric antigen receptors (CARs) from bench-to-bedside.
@en
Chimeric antigen receptors
@nl
prefLabel
Chimeric antigen receptors (CARs) from bench-to-bedside.
@en
Chimeric antigen receptors
@nl
P2860
P1433
P1476
Chimeric antigen receptors (CARs) from bench-to-bedside.
@en
P2093
Barbara Savoldo
Gianpietro Dotti
P2860
P356
10.1016/J.IMLET.2013.09.014
P577
2013-09-27T00:00:00Z